Related Experiment Video

Updated: Jul 15, 2026

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model
07:01

A Quantitative Detection Method for MicroRNAs in the Kidney of an Ischemic Kidney Injury Mouse Model

Published on: September 11, 2020

The detection of myocardial ischemia in end-stage renal disease

Rajan Sharma1, Denis Pellerin, Stephen J D Brecker

  • 1Ealing Hospital NHS Trust, Uxbridge Road. Southal, Middlesex UB1 3HW UK. rajdoc.sharma@tiscali.co.uk

Current Opinion in Investigational Drugs (London, England : 2000)
|April 6, 2007
PubMed

Insights

Early detection of myocardial ischemia is crucial for patients with end-stage renal disease (ESRD). This review examines advanced diagnostic tools for identifying silent ischemia in ESRD patients, improving cardiac event prediction.

Area of Science:

  • Cardiology
  • Nephrology
  • Diagnostic Imaging

Background:

  • Patients with end-stage renal disease (ESRD) have poor outcomes following acute coronary syndromes.
  • Diagnosing myocardial ischemia in ESRD patients is challenging due to unreliable cardiac symptoms and electrocardiography (ECG).
  • Silent ischemia and abnormal resting ECG are common in ESRD, necessitating alternative diagnostic approaches.

Purpose of the Study:

  • To review and evaluate alternative diagnostic methods for myocardial ischemia in patients with ESRD.
  • To explore the utility of myocardial perfusion imaging, dobutamine stress echocardiography, and biochemical markers.
  • To assess the role of these methods in ischemia diagnosis and risk stratification for ESRD patients.

Main Methods:

  • Review of current literature on diagnostic modalities for myocardial ischemia in ESRD.
  • Analysis of studies utilizing myocardial perfusion imaging (MPI).
  • Evaluation of dobutamine stress echocardiography (DSE) in this patient population.
  • Assessment of various biochemical markers for ischemia detection.

Main Results:

  • Myocardial perfusion imaging and dobutamine stress echocardiography show promise in detecting ischemia in ESRD patients.
  • Biochemical markers may offer additional value in risk stratification.
  • These advanced techniques can overcome limitations of traditional methods like ECG and clinical symptoms.

Conclusions:

  • Myocardial perfusion imaging and dobutamine stress echocardiography are valuable tools for diagnosing ischemia in ESRD.
  • Biochemical markers can aid in risk stratification, complementing imaging techniques.
  • Improved diagnostic strategies are essential for better management of cardiac conditions in ESRD patients.

More Related Videos

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats06:38

Early Detection of Drug-Induced Renal Hemodynamic Dysfunction Using Sonographic Technology in Rats

Published on: March 11, 2016

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Diabetic Nephropathy01:28

Diabetic Nephropathy

Definition Diabetic nephropathy is a chronic kidney complication that results from prolonged hyperglycemia.Prevalence It is the most common cause of chronic kidney disease (CKD) and end-stage renal disease (ESRD) worldwide, affecting up to half of individuals with diabetes.Pathophysiology • Sustained hyperglycemia triggers multiple hemodynamic and metabolic changes in the kidney. • Early in the disease, increased renal blood flow and glomerular hyperfiltration occur due to afferent arteriolar...